相关实验视频

Updated: May 12, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

在印度实施CAR-T细胞治疗计划

Hema Hotchandani1, Manju Sengar1, Alok Shetty1

  • 1Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.

Expert review of anticancer therapy
|May 8, 2025
PubMed
概括

印度的土著CAR-T细胞疗法为血液癌症患者提供了希望,但制造,成本和物流方面的挑战仍然存在. 需要制定战略来提高可访问性,并为更好的结果量身定制治疗方法.

关键词:
在CAR-T细胞中.急性淋巴细胞白血病急性淋巴细胞白血病挑战 挑战 挑战 挑战 挑战仿制性抗原受体的复制性受体.血液学的恶性瘤.免疫疗法 免疫疗法其他非霍奇金淋巴瘤.机会 机会 机会 机会

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

378
Generation of Human Chimeric Antigen Receptor Regulatory T Cells10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.1K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401